Atlas market file · Equity · United States
Afya LtdAFYA
- Last close
- 13.91
- Change
- +2.05%
- 96-bar range
- 13.37 – 16.16
- As of
- 6 Aug 2026
Afya Ltd is a services-educational services issuer listed as AFYA on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-23.45% over the window).
Source rail: Yahoo Finance chart API (AFYA). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for AFYA. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
AFYA public profile
Services-educational services issuer. Afya Ltd is connected to current market context, cited company sources and its retained research file.
Afya Ltd trades as AFYA on NASDAQ. Afya Ltd (AFYA) has a latest verified close of 13.91, up 2.05%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files AFYA under USA Stocks for browsing.
What changed for Afya Ltd today
Afya’s investor rail has parked the next earnings date on the calendar like a student parking for finals: Wednesday, 13 August 2026, when the company will finally translate its glossy pitch into hard numbers. Until then, the only official evidence that Afya is anything more than a marketing machine is the promise of a Q2 and H1 2026 results release and a series of product pages that look like they were designed by a med-school admissions committee on a sugar rush. (source: Afya Limited to Report Second Quarter and First Half 2026 Financial Results on August 13th, https://ir.afya.com.br/)
Afya is a Brazilian education and healthcare group whose “essence,” according to its homepage, is to build bridges between cultures and traditions. In practice, that essence translates into operating medical schools, teaching hospitals, and an online education platform called Afya EAD, which sells distance-learning seats to students who may or may not end up staffing the same network’s clinics. The company’s product rail leans heavily on smiling students and clinicians, but the only operational metrics the public sources supply today are course catalogues and campus maps, not enrolment volumes, revenue per student, or cash collected. (source: Conheça os cursos, polos e unidades da Afya que oferecem cursos EAD!, https://ead.afya.com.br/)
What the investor-facing rail does supply is a single concrete fact: Afya will report its second-quarter and first-half 2026 financial results on 13 August 2026. The rail provides no revenue, profit, EPS, cash flow, or guidance figures, so any attempt to value the franchise must wait for that filing. The company’s marketing pages, meanwhile, use images of clinicians and campuses to imply a cohesive ecosystem-students train here, then staff clinics there-while the evidence offers no proof of integrated economics beyond the corporate brand. (source: Afya Limited to Report Second Quarter and First Half 2026 Financial Results on August 13th, https://ir.afya.com.br/)
Afya’s current product rail offers three entry points: the investor newsroom, the Afya EAD online-course portal, and the Brazilian consumer site. The investor newsroom supplies only event dates and corporate imagery; the EAD portal lists courses and campuses but supplies no enrolment or revenue data; the consumer site features mission statements and stock photos. The absence of operational metrics on the public rails means the source requires readers to rely on the 13 August 2026 filing to anchor valuation. The company’s online education platform, Afya EAD, appears designed to recruit students into Afya-branded medical training, yet the evidence does not quantify student counts, pricing, or segment margins. Until the filing lands, Afya remains a brand with a calendar and a promise rather than a measurable business. (source: Afya | Home, https://www.afya.com.br/)
There is The source-change rail is filing/source-led and does not use chart-derived signals. Chart context is available separately on this page through the Atlas chart snapshot or TradingView route where available. Investors seeking chart context should consult their broker’s data feed; this file cites only the company’s own rails. The absence of a chart route from the evidence means the report cannot assert intraday levels, support or resistance, or trading volume beyond what the company discloses-which, for now, is nothing. (source: company product and investor rails, https://ir.afya.com.br/; https://ead.afya.com.br/; https://www.afya.com.br/)
Sources & evidence · 5 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
AFYA technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on AFYA
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep AFYA research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
AFYA FAQ
What is Afya Ltd (AFYA)?Afya Ltd (AFYA) has a latest verified close of 13.91, up 2.05%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks...
Afya Ltd (AFYA) has a latest verified close of 13.91, up 2.05%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for AFYA?Afya Ltd (AFYA) has a latest verified close of 13.91, up 2.05%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the...
Afya Ltd (AFYA) has a latest verified close of 13.91, up 2.05%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files AFYA under USA Stocks for browsing.
How often is the AFYA page updated?The AFYA public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The AFYA public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for AFYA?The AFYA file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:AFYA. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The AFYA file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:AFYA. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on AFYA?Yes. The workstation can open AFYA, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open AFYA, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this AFYA page investment advice?No. The AFYA page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The AFYA page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
AFYA
Equity · evidence first